Associated research groups:

Dimopoulos MA, Voorhees PM, Schjesvold F, Cohen YC, Hungria V, Sandhu I, Lindsay J, Baker RI, Suzuki K, Kosugi H, Levin MD, Beksac M, Stockerl-Goldstein K, Oriol A, Mikala G, Garate G, Theunissen K, Spicka I, Mylin AK, Bringhen S, Uttervall K, Pula B, Medvedova E, Cowan AJ, Moreau P et al. (2024)
Daratumumab or Active Monitoring for High-Risk Smoldering Multiple Myeloma
N Engl J Med (in press)
DOI 10.1056/NEJMoa2409029, PubMed 39652675

Rosenberg T, Möller S, Abildgaard N, Nørgaard JN, Lysén A, Tsykonova G, Joao C, Vangsted A, Schjesvold F, Nielsen LK (2024)
Health-Related Quality of Life During Carfilzomib-Lenalidomide-Dexamethasone Consolidation: Findings From the Multiple Myeloma CONPET Study
Eur J Haematol (in press)
DOI 10.1111/ejh.14358, PubMed 39638553

Askeland FB, Frøen HM, Bolstad N, Thorsby PM, Schjesvold F, Wammer ACP, Følling I, Tjønnfjord GE (2024)
Monoclonal Insulin Autoimmune Syndrome Successfully Treated With Plasma Cell Directed Therapy
Clin Lymphoma Myeloma Leuk (in press)
DOI 10.1016/j.clml.2024.10.005, PubMed 39500643